Protocol R668-EE-1774: A Phase 3, Randomized, 3-Part Study To Investigate The Efficacy And Safety Of Dupilumab In Adult And Adolescent Patients With Eosinophilic Esophagitis.

Project: Research project

Project Details

StatusActive
Effective start/end date5/1/195/1/22

Funding

  • inVentiv Health Clinical (Protocol R668-EE-1774)
  • Regeneron Pharmaceuticals, Inc. (Protocol R668-EE-1774)